4-([1,1'-biphenyl]-3-yl)butanoic acid | 25663-67-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-([1,1'-biphenyl]-3-yl)butanoic acid
• 英文别名: γ-(3-Biphenylyl)-buttersaeure；m-Xenylbuttersaeure；4-(3-Phenylphenyl)butanoic acid
• CAS: 25663-67-6
• 化学式: C₁₆H₁₆O₂
• 分子量: 240.302
• InChiKey: XNMKXSZNLUXTLK-UHFFFAOYSA-N

物化性质

• 熔点：
  110.8-111.5 °C
• 沸点：
  409.8±14.0 °C(Predicted)
• 密度：
  1.116±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-([1,1'-biphenyl]-3-yl)butanoic acid 在 甲烷磺酸 作用下， 反应 3.0h， 生成 7-phenyl-4-[2-(3-phenylphenyl)ethyl]-1,2-dihydronaphthalene
  参考文献：
  名称：

  Synthesis of some tetrahydrochrysenes as potential ultraviolet laser dyes

  摘要：

  DOI：

  10.1021/jo00394a039
• 作为产物：
  描述：

  4-二苯并噻吩-2-基丁酸 在 sodium hydroxide 、 仲辛醇 、 镍 作用下， 生成 4-([1,1'-biphenyl]-3-yl)butanoic acid
  参考文献：
  名称：

  Synthesis of some tetrahydrochrysenes as potential ultraviolet laser dyes

  摘要：

  DOI：

  10.1021/jo00394a039

文献信息

• Ligand‐Controlled Regiodivergence in Nickel‐Catalyzed Hydroarylation and Hydroalkenylation of Alkenyl Carboxylic Acids**
  作者：Zi‐Qi Li、Yue Fu、Ruohan Deng、Van T. Tran、Yang Gao、Peng Liu、Keary M. Engle

  DOI：10.1002/anie.202010840

  日期：2020.12.14

  the ligand environment around the metal center dictates the regiochemical outcome. Markovnikov hydrofunctionalization products are obtained under mild ligand‐free conditions, with up to 99 % yield and >20:1 selectivity. Alternatively, anti‐Markovnikov products can be accessed with a novel 4,4‐disubstituted Pyrox ligand in excellent yield and >20:1 selectivity. Both electronic and steric effects on the

  据报道，镍催化的未活化链烯基羧酸的区域发散性氢芳基化和氢烯基化，从而金属中心周围的配体环境决定了区域化学结果。Markovnikov加氢官能化产物是在无配体的温和条件下获得的，产率高达99％，选择性> 20：1。另外，可以使用新型的4,4-二取代的Pyrox配体获得抗Markovnikov产物，并具有优异的收率和> 20：1的选择性。对配体的电子和空间效应都有助于高产率和选择性。机理研究表明，最佳配体引起的营业额限制和选择性决定步骤发生了变化。DFT计算表明，在反马尔科夫尼科夫途径中，
• 3-phenyl-5,6-dihydrobenz (C) - acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
  申请人：THE DU PONT MERCK PHARMACEUTICAL COMPANY

  公开号：EP0380038A2

  公开（公告）日：1990-08-01

  Dihydrobenz[c]acridine carboxylic acid derivatives are provided which are useful in treating tumors in mammals. These dihydrobenz[c]acridine carboxylic acid derivatives have the formula: or a pharmaceutically acceptable salt thereof, where R¹, R², R³, R⁴ and R⁵ are as defined in the specification. Also provided are pharmaceutical compositions of said compounds. In addition, processes for the preparation of these compounds are disclosed.

  提供了可用于治疗哺乳动物肿瘤的二氢苯并[c]吖啶羧酸衍生物。这些二氢苯并[c]吖啶羧酸衍生物的化学式为 或其药学上可接受的盐，其中 R¹、R²、R³、R⁴ 和 R⁵ 如说明书中所定义。还提供了上述化合物的药物组合物。此外，还公开了制备这些化合物的工艺。
• LYLE T. A.; DAUB G. H., J. ORG. CHEM., 1979, 44, NO 26, 4933-4938
  作者：LYLE T. A.、 DAUB G. H.

  DOI：——

  日期：——
• COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH ER STRESS
  申请人：Uysal Teoman

  公开号：US20090131384A1

  公开（公告）日：2009-05-21

  The invention provides novel compounds, methods for treating or preventing a condition related to ER-stress, e.g. hypercholesterolemia, atherosclerosis and related conditions, and pharmaceutical compositions related thereto.
• Compounds and Methods of Use Thereof for Treating Tumors
  申请人：Georgetown University

  公开号：US20150344440A1

  公开（公告）日：2015-12-03

  The invention encompasses novel compounds and pharmaceutically acceptable salts thereof and compositions including therapeutically or prophylactically effective amounts of such compounds or pharmaceutically acceptable salts thereof. The invention also encompasses methods for treating or preventing diseases and disorders associated with abnormal cell growth, for example, treating or preventing cancer or tumor growth, which methods include administering to a mammal in need thereof a composition comprising a therapeutically or prophylactically effective amount of a compound of the invention or a pharmaceutically acceptable salt thereof.